Keros Therapeutics (KROS) EBT (2019 - 2025)
Keros Therapeutics (KROS) posted EBT of -$25.0 million for Q4 2025, down 186.94% on a QoQ basis from -$8.7 million in Q3 2025, and up 45.38% year-over-year from -$17.2 million in Q4 2024.
Keros Therapeutics (KROS) EBT (2019 - 2025) Analysis & Trends
Keros Therapeutics' EBT history runs 7 years deep, the most recent figure standing at -$25.0 million for Q4 2025.
- Quarterly EBT rose 45.38% year-over-year to -$25.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.9 million (up 149.13% YoY) and the FY2025 annual result came in at $91.9 million, up 149.13% from the prior year.
- EBT was -$25.0 million for Q4 2025 at Keros Therapeutics, down from -$8.7 million in the prior quarter.
- Across five years, EBT topped out at $158.5 million in Q1 2025 and bottomed at -$91.4 million in Q2 2023.
- A 5-year average of -$25.5 million and a median of -$28.5 million in 2022 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT tumbled 501.46% — and 2025, when it surged 467.62%.
- Keros Therapeutics' EBT stood at -$4.9 million in 2021, then tumbled by 501.46% to -$29.7 million in 2022, then plunged by 53.36% to -$45.6 million in 2023, then declined by 0.33% to -$45.7 million in 2024, then surged by 45.38% to -$25.0 million in 2025.
- Business Quant data shows KROS's EBT at -$25.0 million in Q4 2025, -$8.7 million in Q3 2025, and -$32.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - | -24.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.98 Mn |
| Sep 30, 2025 | -8.70 Mn |
| Jun 30, 2025 | -32.92 Mn |
| Mar 31, 2025 | 158.49 Mn |
| Dec 31, 2024 | -45.73 Mn |
| Sep 30, 2024 | -52.96 Mn |
| Jun 30, 2024 | -45.26 Mn |
| Mar 31, 2024 | -43.11 Mn |
| Dec 31, 2023 | -45.58 Mn |
| Sep 30, 2023 | -76.88 Mn |
| Jun 30, 2023 | -91.44 Mn |
| Mar 31, 2023 | -39.37 Mn |
| Dec 31, 2022 | -29.72 Mn |
| Sep 30, 2022 | -23.51 Mn |
| Jun 30, 2022 | -27.27 Mn |
| Mar 31, 2022 | -24.19 Mn |
| Dec 31, 2021 | -4.94 Mn |
| Sep 30, 2021 | -20.34 Mn |
| Jun 30, 2021 | -15.62 Mn |
| Mar 31, 2021 | -15.84 Mn |